Straumann Holding AG, trading on the OTC Markets under the ticker SAUHY, is a global leader in restorative and regenerative dentistry. Founded in 1954 and headquartered in Basel, Switzerland, the company develops, manufactures and markets dental implant systems, prosthetic components and biomaterials. Straumann serves dentists, dental laboratories and clinics, offering solutions designed to improve patient outcomes through reliable implant therapy and tissue regeneration.
The company’s core product portfolio includes endosseous implants manufactured from high-performance titanium and ceramic materials, as well as abutments, surgical instruments and patient-specific prosthetic solutions. Straumann has expanded its offerings through strategic acquisitions of brands such as Neodent, Anthogyr and Medentika, enabling a broad range of implant designs and restorative options. In addition, its biomaterials division supplies bone grafts, membranes and sealants to support soft and hard tissue augmentation procedures.
In recent years, Straumann has accelerated its digital dentistry initiatives with intraoral scanners, 3D imaging software and guided surgery platforms. The company also collaborates with orthodontic partners to provide clear aligner therapy under the ClearCorrect brand. Its Research & Development centers in Europe and North America focus on advancing digital workflows, biomaterial science and minimally invasive surgical techniques through ongoing clinical studies and partnerships with academic institutions.
With a presence in over 70 countries, Straumann operates regional subsidiaries across Europe, the Americas, Asia-Pacific and the Middle East. The company’s global distribution network includes direct sales forces and authorized distributors, supporting dental professionals through training programs and digital education portals. As of 2023, Straumann’s executive leadership is headed by Chief Executive Officer Guillaume Daniellot, under whose guidance the company continues to pursue innovation in dental restoration and regenerative therapies.
AI Generated. May Contain Errors.
MarketBeat All Access